Clean Science promoter group transfers 9.5% stake via gift

1 min read     Updated on 02 Jun 2026, 05:44 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Members of the promoter group of Clean Science and Technology will transfer 1,01,00,000 equity shares (9.50%) via inter-se gift on or after June 6, 2026. The transaction involves Mrs. Asha Ashok Boob transferring shares to AAB Business Trust, with no consideration involved. The transfer is exempt under SEBI SAST Regulations and aims to streamline family assets.

powered bylight_fuzz_icon
41852046

*this image is generated using AI for illustrative purposes only.

Members of the promoter group of clean science & technology will transfer 1,01,00,000 equity shares, representing 9.50% of the paid-up share capital, via inter-se gift on or after June 6, 2026. The transaction involves Mrs. Asha Ashok Boob transferring shares to AAB Business Trust. The transfer aims to streamline the family's assets and businesses, and the aggregate holding of the promoter and promoter group remains unchanged before and after the transaction.

The transfers fall under the exemption provided by Regulation 10(1)(a)(ii) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. As the transactions are gifts, no consideration is involved. The company confirmed receipt of the information from the acquirers on June 1, 2026.

Shareholding Pattern

The disclosure details the shift in shareholding between the donor and donee within the promoter group. The following table outlines the proposed transfers:

Transferor Transferee Shares Transferred % of Total Capital
Asha Ashok Boob AAB Business Trust 1,01,00,000 9.50
Total 1,01,00,000 9.50

Transaction Details

The acquisition involves equity shares of Re. 1 each. The acquirers have confirmed compliance with the applicable disclosure requirements under Chapter V of the Takeover Regulations. Prior to the transaction, AAB Business Trust held 100 shares (0.00%), which will increase to 1,01,00,100 shares (9.50%) post-transfer. Conversely, Mrs. Asha Ashok Boob's holding will decrease from 1,01,98,392 shares (9.60%) to 98,392 shares (0.09%).

A note in the disclosure states that Asha Ashok Boob is in the process of an additional inter-se transfer, pursuant to which she proposes to receive a gift of 8,38,000 shares from Mrs. Nilima Krishnakumar Boob. Upon completion of that transfer, her total shareholding will increase to 9,36,392 shares, representing 0.88% of the total share capital.

Historical Stock Returns for Clean Science & Technology

1 Day5 Days1 Month6 Months1 Year5 Years
-1.24%+4.08%-4.21%-13.78%-46.31%-50.32%

What are the long-term strategic benefits of moving assets into a trust structure for the promoter group?

Could this restructuring signal potential changes in the family's succession planning or governance?

How might the increased holding of AAB Business Trust influence future voting decisions within the promoter group?

Clean Science & Technology
View Company Insights
View All News
like17
dislike

Clean Science FY26 PAT Falls 14%, Declares ₹4 Dividend

5 min read     Updated on 21 May 2026, 07:06 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Clean Science & Technology reported a 14% decline in FY26 standalone PAT to ₹251 crore, with revenue decreasing to ₹815 crore. The Board recommended a final dividend of ₹4 per share and approved an additional ₹200 crore investment in subsidiary Clean Fino-Chem Limited.

powered bylight_fuzz_icon
40302452

*this image is generated using AI for illustrative purposes only.

Clean Science & Technology has announced its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The Board of Directors, at their meeting held on May 14, 2026, approved the financial results and recommended a final dividend of ₹4 per equity share of face value ₹1 each for FY26, subject to shareholder approval at the ensuing Annual General Meeting. The statutory auditors, Price Waterhouse Chartered Accountants LLP, issued an unmodified audit opinion on both standalone and consolidated financial results. In compliance with Regulation 30 read with Schedule III and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company also confirmed the publication of the audited financial results in Business Standard (English edition) and Loksatta (Marathi edition) on May 15, 2026, as well as the upload of the audio recording of its Q4 FY26 Earnings Conference Call on its official website.

Standalone Financial Performance

On a standalone basis, the company reported revenue from operations of ₹815 crore for FY26, a decline from ₹922 crore in FY25. Standalone profit after tax (PAT) for the year stood at ₹251 crore, a decrease of 14% from ₹292 crore in the previous year. Despite the revenue decline, standalone EBITDA margins remained resilient at 44.3% for FY26, compared to 44.0% in FY25. For the quarter ended March 31, 2026, standalone revenue from operations was ₹197 crore, lower than ₹245 crore in Q4 FY25, while standalone PAT stood at ₹58.10 crore compared to ₹78.60 crore in the corresponding quarter of the previous year. On a sequential basis, standalone revenue improved by 6% from ₹185 crore in Q3 FY26, while EBITDA rose by 22% quarter-on-quarter. EBITDA margins recovered to 44.7% in Q4 FY26 from 42.59% in Q4 FY25. During Q4 FY26, the Executive Directors voluntarily elected to forgo a substantial portion of their performance bonus entitlement for FY26, resulting in a reversal of earlier provisions and lower employee benefits expense for the quarter.

The following table summarises the key standalone and consolidated financial metrics:

Metric: Q4 FY26 Q3 FY26 Q4 FY25 FY26 FY25
Standalone Revenue (₹ Crore): 197 185 245 815 922
Standalone EBITDA (₹ Crore): 88.10 72 105 353 399
Standalone EBITDA %: 44.7% 40.3% 42.59% 44.3% 44.0%
Standalone PAT (₹ Crore): 58.10 52 78.60 251 292
Consolidated Revenue (₹ Crore): 249 - 264 957 967
Consolidated PAT (₹ Crore): 58 - 74 230 266

Consolidated Financial Performance

On a consolidated basis, the company reported revenue from operations of ₹957 crore for FY26, a marginal decrease from ₹967 crore in FY25. Consolidated PAT for the year stood at ₹230 crore, a decline of 13% from ₹266 crore in FY25. Consolidated EBITDA stood at ₹355 crore with margins at 37.7%, compared to ₹388 crore and 40.8% in the prior year. The consolidated results include the financial performance of four wholly owned subsidiaries: Clean Fino-Chem Limited, Clean Science Private Limited, Clean Aromatics Private Limited, and Clean Organics Private Limited. The Group is exclusively engaged in the manufacturing of organic chemicals, constituting a single primary operating segment as per Ind AS 108.

The standalone statement of assets and liabilities as at March 31, 2026 reflects total assets of ₹17,839.51 million, compared to ₹16,048.84 million as at March 31, 2025. Total equity stood at ₹16,456.44 million, with other equity at ₹16,350.16 million. On a consolidated basis, total assets were ₹17,829.00 million as at March 31, 2026, against ₹16,077.60 million in the prior year, with total equity at ₹15,837.71 million.

Earnings Per Share

The standalone basic earnings per share (EPS) for FY26 stood at ₹23.64, compared to ₹27.51 in FY25. Diluted EPS was ₹23.63 for FY26 against ₹27.50 in FY25. For Q4 FY26, standalone basic EPS was ₹5.47 and diluted EPS was ₹5.46. On a consolidated basis, basic EPS for FY26 was ₹21.61 and diluted EPS was ₹21.60, compared to ₹24.88 each in FY25.

EPS Metric: Q4 FY26 Q4 FY25 FY26 FY25
Standalone Basic EPS (₹): 5.47 7.40 23.64 27.51
Standalone Diluted EPS (₹): 5.46 7.40 23.63 27.50
Consolidated Basic EPS (₹): 5.48 6.97 21.61 24.88
Consolidated Diluted EPS (₹): 5.48 6.97 21.60 24.88

Corporate Actions and Other Developments

The Board recommended a final dividend of ₹4 per equity share of face value ₹1 each for FY26, implying a total payout ratio of 25% for the year. The book closure and dividend payment date will be determined later. The Board also approved an additional investment of ₹200 crore in one or more tranches in Clean Fino-Chem Limited, a wholly owned subsidiary. The company incurred a total capex of approximately ₹220 crore during FY26, primarily towards investment in its subsidiary. During FY26, 10,040 equity shares of ₹1 each fully paid-up were allotted upon exercise of vested stock options pursuant to the Company's Employee Stock Option Scheme, 2021 (ESOP 2021). The Board also approved the re-appointment of M/s CNK JBMS & Associates as Internal Auditors and M/s Dhananjay V. Joshi & Associates as Cost Auditors, both for FY 2026-27.

Regulatory Disclosures and Earnings Call

Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Clean Science & Technology submitted copies of the newspaper advertisement published in Business Standard (English edition) and Loksatta (Marathi edition) on May 15, 2026, confirming the audited financial results for the quarter and financial year ended March 31, 2026. The company also confirmed the upload of the audio recording of its Q4 FY26 Earnings Conference Call, held on May 14, 2026, on the company's official website. Both submissions were made by Ruchita Vij, Company Secretary and Compliance Officer.

Source: Company/INE227W01023

Historical Stock Returns for Clean Science & Technology

1 Day5 Days1 Month6 Months1 Year5 Years
-1.24%+4.08%-4.21%-13.78%-46.31%-50.32%

How will the ₹200 crore additional investment in Clean Fino-Chem Limited translate into revenue growth, and what new product lines or capacity expansions are planned for FY27?

Given the persistent standalone revenue decline from ₹922 crore in FY25 to ₹815 crore in FY26, what pricing pressures or demand shifts in the specialty chemicals sector could continue to weigh on Clean Science's top line?

With consolidated EBITDA margins compressing from 40.8% to 37.7% year-on-year, can the company sustain its industry-leading profitability amid rising competition from Chinese chemical manufacturers?

Clean Science & Technology
View Company Insights
View All News
like20
dislike

More News on Clean Science & Technology

1 Year Returns:-46.31%